Healthcare entity

Regentis Biomaterials Ltd

Company

All 1 tracked stories fall under one category: medical-devices. Regentis Biomaterials Ltd is most often covered alongside GelrinC, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 3.1 across the same-window beat baseline.

Last mentioned: Mar 17, 2026

Entity pulse

Recent coverage · Regentis Biomaterials Ltd

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Regentis Biomaterials Ltd

All 1 tracked stories fall under one category: medical-devices. Regentis Biomaterials Ltd is most often covered alongside GelrinC, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 3.1 across the same-window beat baseline. At 7, the average consequence score sits above the same-window beat average of 6.3. We currently track 1 Healthcare story that mention Regentis Biomaterials Ltd, all published on March 17, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 34 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Regentis Biomaterials Ltd. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Regentis Biomaterials Ltd 1

Medical Devices Strongly positive

Regentis Biomaterials Scales GelrinC Production with 400% Yield Increase

Regentis Biomaterials has patented a breakthrough solvent-free manufacturing process for its GelrinC hydrogel, achieving a 400% increase in production yield. This advancement positions the company for large-scale commercialization while improving the environmental profile and cost-efficiency of its cartilage repair solution.

2 sources

Source: finanznachrichten.de · tennesseedaily.com

Regentis Biomaterials Ltd is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.